Receptor for advanced glycation end products is protective during murine tuberculosis

Molecular Immunology

Volumn 52, Issue 3-4, 2012, Pages 183-189

  van Zoelen, Marieke A D ^a,b   Wieland, Catharina W ^a   van der Windt, Gerritje J W ^a   Florquin, Sandrine ^a   Nawroth, Peter P ^c   Bierhaus, Angelika ^c   van der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Host defense, Infection; Mycobacterium tuberculosis; Receptor for advanced glycation end products; Tuberculosis

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CHEMOKINE; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; HISTOPATHOLOGY; LUNG WEIGHT; MORTALITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUBERCULOSIS; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; BACTERIAL LOAD; CHEMOKINES; CYTOKINES; LEUKOCYTE COUNT; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHILS; RECEPTORS, IMMUNOLOGIC; TUBERCULOSIS, PULMONARY;

MURINAE; MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 84861979746     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.05.014     Document Type: Article

References (46)

1. Ben-Sasson S.Z., Caucheteux S., Crank M., Hu-Li J., Paul W.E. IL-1 acts on T cells to enhance the magnitude of in vivo immune responses. Cytokine 2011, 56:122-125.
2. Bierhaus A., Schiekofer S., Schwaninger M., Andrassy M., Humpert P.M., Chen J., Hong M., Luther T., Henle T., Kloting I., Morcos M., Hofmann M., Tritschler H., Weigle B., Kasper M., Smith M., Perry G., Schmidt A.M., Stern D.M., Haring H.U., Schleicher E., Nawroth P.P. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001, 50:2792-2808.
3. Cataldegirmen G., Zeng S., Feirt N., Ippagunta N., Dun H., Qu W., Lu Y., Rong L.L., Hofmann M.A., Kislinger T., Pachydaki S.I., Jenkins D.G., Weinberg A., Lefkowitch J., Rogiers X., Yan S.F., Schmidt A.M., Emond J.C. RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB. Journal of Experimental Medicine 2005, 201:473-484.
4. Chavakis T., Bierhaus A., Al Fakhri N., Schneider D., Witte S., Linn T., Nagashima M., Morser J., Arnold B., Preissner K.T., Nawroth P.P. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. Journal of Experimental Medicine 2003, 198:1507-1515.
5. Chavakis T., Bierhaus A., Nawroth P.P. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes and Infection 2004, 6:1219-1225.
6. Cheng C., Tsuneyama K., Kominami R., Shinohara H., Sakurai S., Yonekura H., Watanabe T., Takano Y., Yamamoto H., Yamamoto Y. Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs. Modern Pathology 2005, 18:1385-1396.
7. Constien R., Forde A., Liliensiek B., Grone H.J., Nawroth P., Hammerling G., Arnold B. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 2001, 30:36-44.
8. Curtis M.M., Way S.S. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 2009, 126:177-185.
9. Deane R., DU Y.S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A.M., Armstrong D.L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nature Medicine 2003, 9:907-913.
10. Dye C., Williams B.G. The population dynamics and control of tuberculosis. Science 2010, 328:856-861.
11. Ekong U., Zeng S., Dun H., Feirt N., Guo J., Ippagunta N., Guarrera J.V., Lu Y., Weinberg A., Qu W., Ramasamy R., Schmidt A.M., Emond J.C. Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice. Journal of Gastroenterology and Hepatology 2006, 21:682-688.
12. Englert J.M., Hanford L.E., Kaminski N., Tobolewski J.M., Tan R.J., Fattman C.L., Ramsgaard L., Richards T.J., Loutaev I., Nawroth P.P., Kasper M., Bierhaus A., Oury T.D. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. American Journal of Pathology 2008, 172:583-591.
13. Flynn J.L., Chan J. Immunology of tuberculosis. Annual Review of Immunology 2001, 19:93-129.
14. Flynn J.L., Chan J. What's good for the host is good for the bug. Trends in Microbiology 2005, 13:98-102.
15. Goova M.T., Li J., Kislinger T., Qu W., Lu Y., Bucciarelli L.G., Nowygrod S., Wolf B.M., Caliste X., Yan S.F., Stern D.M., Schmidt A.M. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. American Journal of Pathology 2001, 159:513-525.
16. He M., Kubo H., Ishizawa K., Hegab A.E., Yamamoto Y., Yamamoto H., Yamaya M. The role of the receptor for advanced glycation end-products in lung fibrosis. American Journal of Physiology - Lung Cellular and Molecular Physiology 2007, 293:L1427-L1436.
17. Hofmann M.A., Drury S., Hudson B.I., Gleason M.R., Qu W., Lu Y., Lalla E., Chitnis S., Monteiro J., Stickland M.H., Bucciarelli L.G., Moser B., Moxley G., Itescu S., Grant P.J., Gregersen P.K., Stern D.M., Schmidt A.M. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes and Immunity 2002, 3:123-135.
18. Kaufmann S.H. How can immunology contribute to the control of tuberculosis?. Nature Reviews Immunology 2001, 1:20-30.
19. Kislinger T., Fu C., Huber B., Qu W., Taguchi A., Du Y.S., Hofmann M., Yan S.F., Pischetsrieder M., Stern D., Schmidt A.M. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. Journal of Biological Chemistry 1999, 274:31740-31749.
20. Lee W.W., Kang S.W., Choi J., Lee S.H., Shah K., Eynon E.E., Flavell R.A., Kang I. Regulating human Th17 cells via differential expression of IL-1 receptor. Blood 2010, 115:530-540.
21. Leemans J.C., Florquin S., Heikens M., Pals S.T., van der Neut R., van der Poll T. CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis. Journal of Clinical Investigation 2003, 111:681-689.
22. Leemans J.C., Vervoordeldonk M.J., Florquin S., van Kessel K.P., van der Poll T. Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus. American Journal of Respiratory and Critical Care Medicine 2002, 165:1445-1450.
23. Liliensiek B., Weigand M.A., Bierhaus A., Nicklas W., Kasper M., Hofer S., Plachky J., Grone H.J., Kurschus F.C., Schmidt A.M., Yan S.D., Martin E., Schleicher E., Stern D.M., Hammerling G.G., Nawroth P.P., Arnold B. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. Journal of Clinical Investigation 2004, 113:1641-1650.
24. Maartens G., Wilkinson R.J. Tuberculosis. Lancet 2007, 370:2030-2043.
25. Miossec P., Korn T., Kuchroo V.K. Interleukin-17 and type 17 helper T cells. New England Journal of Medicine 2009, 361:888-898.
26. Morbini P., Villa C., Campo I., Zorzetto M., Inghilleri S., Luisetti M. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease?. Modern Pathology 2006, 19:1437-1445.
27. Moroz O.V., Antson A.A., Dodson E.J., Burrell H.J., Grist S.J., Lloyd R.M., Maitland N.J., Dodson G.G., Wilson K.S., Lukanidin E., Bronstein I.B. The structure of S100A12 in a hexameric form and its proposed role in receptor signalling. Acta Crystallographica. Section D: Biological Crystallography 2002, 58:407-413.
28. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., Elliston K., Stern D., Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. Journal of Biological Chemistry 1992, 267:14998-15004.
29. Park L., Raman K.G., Lee K.J., Lu Y., Ferran L.J., Chow W.S., Stern D., Schmidt A.M. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nature Medicine 1998, 4:1025-1031.
30. Peters W., Ernst J.D. Mechanisms of cell recruitment in the immune response to Mycobacterium tuberculosis. Microbes and Infection 2003, 5:151-158.
31. Russell D.G., Barry C.E., Flynn J.L. Tuberculosis: what we don't know can, and does, hurt us. Science 2010, 328:852-856.
32. Schmidt A.M., Vianna M., Gerlach M., Brett J., Ryan J., Kao J., Esposito C., Hegarty H., Hurley W., Clauss M. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. Journal of Biological Chemistry 1992, 267:14987-14997.
33. Sorci G., Riuzzi F., Arcuri C., Giambanco I., Donato R. Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding. Molecular and Cellular Biology 2004, 24:4880-4894.
34. Tufariello J.M., Chan J., Flynn J.L. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infectious Diseases 2003, 3:578-590.
35. Uchida T., Shirasawa M., Ware L.B., Kojima K., Hata Y., Makita K., Mednick G., Matthay Z.A., Matthay M.A. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. American Journal of Respiratory and Critical Care Medicine 2006, 173:1008-1015.
36. Valencia J.V., Mone M., Zhang J., Weetall M., Buxton F.P., Hughes T.E. Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA. Diabetes 2004, 53:743-751.
37. van Zoelen M.A., Achouiti A., van der Poll T. RAGE during infectious diseases. Frontiers in Bioscience (Scholar Edition) 2011, 3:1119-1132.
38. van Zoelen M.A., Achouiti A., van der Poll T. The role of receptor for advanced glycation endproducts (RAGE) in infection. Critical Care 2011, 15:208.
39. van Zoelen M.A., Florquin S., Braun-Pater J.M., Verstege M.I., Meijers J.C., van der Poll T. Urokinase plasminogen activator receptor-deficient mice demonstrate reduced hyperoxia-induced lung injury. American Journal of Pathology 2009, 174:2182-2189.
40. van Zoelen M.A., Schouten M., de Vos A.F., Florquin S., Meijers J.C., Nawroth P.P., Bierhaus A., van der Poll T. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. Journal of Immunology 2009, 182:4349-4356.
41. van Zoelen M.A., van der Sluijs K.F., Achouiti A., Florquin S., Braun-Pater J.M., Yang H., Nawroth P.P., Tracey K.J., Bierhaus A., van der Poll T. Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia. Virology 2009, 391:265-273.
42. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., Basham B., Smith K., Chen T., Morel F., Lecron J.C., Kastelein R.A., Cua D.J., McClanahan T.K., Bowman E.P., de Waal M.R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nature Immunology 2007, 8:950-957.
43. Wittkowski H., Sturrock A., van Zoelen M.A., Viemann D., van der Poll T., Hoidal J.R., Roth J., Foell D. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Critical Care Medicine 2007, 35:1369-1375.
44. Yan S.D., Zhu H., Zhu A., Golabek A., Du H., Roher A., Yu J., Soto C., Schmidt A.M., Stern D., Kindy M. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nature Medicine 2000, 6:643-651.
45. Yan S.S., Wu Z.Y., Zhang H.P., Furtado G., Chen X., Yan S.F., Schmidt A.M., Brown C., Stern A., LaFaille J., Chess L., Stern D.M., Jiang H. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system. Nature Medicine 2003, 9:287-293.
46. Zeng S., Feirt N., Goldstein M., Guarrera J., Ippagunta N., Ekong U., Dun H., Lu Y., Qu W., Schmidt A.M., Emond J.C. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology 2004, 39:422-432.